Diaceutics PLC

200.50pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:DXRXHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 8Y CAGR 9.08%
Div yield —
ROE (0.71%)
Medical (Healthcare Information Services)
Beta (5Y) 0.77
PE TTM —
TSR TTM 19.35%
Mkt cap £170.2M
ROIC (2.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
212p
5.72%
280.56%
Hold 8|11|6|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share£
3.50
3.62
3.55
3.92
16.21%
9.96%
5.71%
18.41%
Revenue£M
8.391
8.433
8.305
8.594
(2.53%)
0.15%
(0.89%)
2.30%
Peers (US$231.6M)
Cap (US$)
PE
465.7M
24.17x
359.3M
156.0x
49.74M
—
Capital
TTM
5Y
10Y
Leveragex
0.149
2.474
1.912
EBIT/Intx
0.723
0.118
0.108
Own earn%
37.86
2.52
5.14
Sh yield%
16.33
35.70
34.41
Owners
Insiders/Inst%
0.46
53.54
Short interest%
5.71
SBC / revenue%
5.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
0–6
$1 testx
0.0
Incr. ROIC%
1